NASDAQ:ZIVO ZIVO Bioscience (ZIVO) Stock Price, News & Analysis $8.12 -0.47 (-5.42%) As of 10/30/2026 02:02 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsSEC Filings About ZIVO Bioscience Stock (NASDAQ:ZIVO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ZIVO Bioscience alerts:Sign Up Key Stats Today's Range$8.12▼$8.1250-Day Range$3.11▼$8.5952-Week Range$1.11▼$16.50Volume206 shsAverage Volume2,686 shsMarket Capitalization$34.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview ZIVO Bioscience, Inc. is a biotechnology company focused on developing health and wellness products derived from proprietary algae and other naturally sourced biological materials. Its research platform is designed to identify and develop bioactive compounds with potential applications in human health, animal health and nutritional products. The company’s activities include algae cultivation, ingredient development and preclinical research into compounds that may support immune function and address other health-related needs. ZIVO has pursued opportunities involving dietary supplements, functional foods, animal-health products and pharmaceutical candidates, working to advance selected compounds toward commercialization or licensing. ZIVO Bioscience is based in Bloomfield Hills, Michigan, and has historically focused its development and commercialization efforts on the North American health, nutrition and animal-health markets. The company has operated as a development-stage biotechnology business, with its product pipeline and research programs subject to ongoing testing, regulatory review and potential commercial partnerships.AI Generated. May Contain Errors. Read More Receive ZIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZIVO Stock News HeadlinesZivo Bioscience, Inc. Announces Transition to OTCID MarketplaceMay 12, 2026 | businesswire.comZivo Bioscience Inc. WtApril 11, 2026 | barrons.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.November 1 at 1:00 AM | Weiss Ratings (Ad)ZIVO Bioscience Provides Special Letter to ShareholdersMarch 27, 2026 | businesswire.comMaxim Group Reaffirms Their Hold Rating on Zivo Bioscience (ZIVO)December 15, 2025 | theglobeandmail.comZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic BusinessesSeptember 10, 2025 | businesswire.comZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in PoultryJune 20, 2025 | businesswire.comUniversity of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in PoultryMay 7, 2025 | finance.yahoo.comSee More Headlines ZIVO Stock Analysis - Frequently Asked Questions How have ZIVO shares performed this year? ZIVO Bioscience's stock was trading at $8.70 at the beginning of the year. Since then, ZIVO shares have decreased by 6.7% and is now trading at $8.12. How were ZIVO Bioscience's earnings last quarter? ZIVO Bioscience, Inc. (NASDAQ:ZIVO) released its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.06) earnings per share for the quarter. The biotechnology company earned $20 thousand during the quarter. When did ZIVO Bioscience's stock split? Shares of ZIVO Bioscience reverse split before market open on Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of ZIVO Bioscience? Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ZIVO Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include NIO (NIO), Anglo American (AAL), American Airlines Group (AAL), Abeona Therapeutics (ABEO), Amarin (AMRN), Ares Capital (ARCC) and AST SpaceMobile (ASTS). Company Calendar Last Earnings5/11/2020Today11/01/2026Next Earnings (Estimated)12/02/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ZIVO Previous SymbolOTCMKTS:HEPI CIK1101026 Webwww.zivobioscience.com Phone(248) 452-9866FaxN/AEmployees10Year Founded1999Profitability EPS (Trailing Twelve Months)($1.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.78 million Net MarginsN/A Pretax Margin-17,113.75% Return on EquityN/A Return on Assets-2,240.92% Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.17 Sales & Book Value Annual Sales$15.85 thousand Price / Sales2,159.36 Cash FlowN/A Price / Cash FlowN/A Book Value($0.81) per share Price / Book-10.02Miscellaneous Outstanding Shares4,215,000Free Float2,911,000Market Cap$34.23 million OptionableNot Optionable Beta0.38 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:ZIVO) was last updated on 10/30/2026 by MarketBeat.com Staff. From Our PartnersFinancial Legend: “Big trouble ahead …”Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution ri...Weiss Ratings | SponsoredThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredDoes your nest egg have an expiration date?A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | SponsoredYour free stock pick for todayElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
